Plotkin Financial Advisors’s ProShares Ultra Health Care RXL Stock Holding History

Plotkin Financial Advisors’s Portfolio RXL Stock Details RXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,884	Closed	-$589K	–	94
2023 Q4	$589K	Sell	12,884 -1,922	-13%	-$80.4K	0.45%	35
2023 Q3	$612K	Sell	14,806 -5,668	-28%	-$250K	0.54%	30
2023 Q2	$912K	Buy	20,474 +1,012	+5%	+$44.5K	0.76%	27
2023 Q1	$832K	Buy	19,462 +364	+2%	+$15.9K	0.77%	26
2022 Q4	$903K	Sell	19,098 -12	-0.1%	-$544	0.92%	25
2022 Q3	$737K	Buy	19,110 +834	+5%	+$36.8K	0.75%	27
2022 Q2	$797K	Buy	18,276 +2,200	+14%	+$101K	0.76%	27
2022 Q1	$823K	Buy	16,076 +2,282	+17%	+$110K	0.57%	30
2021 Q4	$772K	Buy	+13,794	New	+$699K	0.49%	36

Other funds holding RXL

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

Plotkin Financial Advisors's RXL Position: Q1 2024 in Review

Plotkin Financial Advisors sold out of ProShares Ultra Health Care (RXL) in Q1 2024, closing a stake of 12,884 shares — an estimated $589K sold.

Plotkin Financial Advisors first reported a position in RXL in Q4 2021 and held it in 9 quarters. The position peaked at $912K in Q2 2023. 17 funds tracked by Wall St. Rank hold RXL as of Q1 2024.

Plotkin Financial Advisors reported no remaining ProShares Ultra Health Care position as of Q1 2024 after selling out during the quarter.
Plotkin Financial Advisors sold 12,884 ProShares Ultra Health Care shares in Q1 2024, an estimated $589K.
Plotkin Financial Advisors first reported a position in ProShares Ultra Health Care in Q4 2021 and held it in 9 quarters.
Plotkin Financial Advisors's ProShares Ultra Health Care position peaked at $912K in Q2 2023.
17 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q1 2024.

Based on Plotkin Financial Advisors's 13F filing for Q1 2024, filed 15 Nov 2024.